NCT00792610View on ClinicalTrials.gov

The Hepatitis B Vaccine Booster Response Among the Youth Who Had Completed Neonatal Hepatitis B Vaccines

NACompletedINTERVENTIONAL
Enrollment

127

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

January 31, 2009

Study Completion Date

February 28, 2009

Conditions
Hepatitis B
Interventions
BIOLOGICAL

hepatitis B vaccine

Recombinant HBsAg, 20mcg/ml/vial (GSK) one vial IM at Day 0, Month 1, month 6 during follow-up, respectively.

Trial Locations (1)

10051

National Taiwan University Hospital, Taipei

All Listed Sponsors
collaborator

National Science and Technology Council, Taiwan

OTHER_GOV

lead

National Taiwan University Hospital

OTHER

NCT00792610 - The Hepatitis B Vaccine Booster Response Among the Youth Who Had Completed Neonatal Hepatitis B Vaccines | Biotech Hunter | Biotech Hunter